RE-BVS – Piemonte Repository

Sfoglia per AUTORE
RIZZO M
Collezione AOU Novara

Items : 18

Assessing the effectiveness and safety of lenvatinib and everolimus in advanced renal cell carcinoma: insights from the RELIEVE study's analysis of heavily pretreated patients. in Therapeutic advances in urology / Ther Adv Urol. 2024 Apr 17;16:17562872241244574. doi: 10.1177/17562872241244574. eCollection 2024 Ja

2024
AOU Novara

Buti S; Olivari A; Masini C; Bimbatti D; Sartori D; Ermacora P; Cattrini C; Vitale MG; Rossi E; Mucciarini C; Rizzo M; Sisani M; Santoni M; Roviello G; Mollica V; Conteduca V; Grillone F; Cinausero M; Prati G; Atzori F; Stellato M; Massari F; Bersanelli M;

Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations: Differential Effectiveness by Risk Group? in European urology oncology / Eur Urol Oncol. 2024 Feb;7(1):102-111. doi: 10.1016/j.euo.2023.07.003. Epub 2023 Jul 21.

2024
AOU Novara

Santoni M; Buti S; Myint ZW; Maruzzo M; Iacovelli R; Pichler M; Kopecky J; Kucharz J; Rizzo M; Galli L; Büttner T; De Giorgi U; Kanesvaran R; Fiala O; Grande E; Zucali PA; Kopp RM; Fornarini G; Bourlon MT; Scagliarini S; Molina-Cerrillo J; Aurilio G; Matrana MR; Pichler R; Cattrini C; Büchler T; Massari F; Seront E; Calabrò F; et alii...

Neutrophil-to-Eosinophil Ratio Predicts the Efficacy of Avelumab in Patients With Advanced Urothelial Carcinoma Enrolled in the MALVA Study (Meet-URO 25). in Clinical genitourinary cancer / Clin Genitourin Cancer. 2024 Aug;22(4):102099. doi: 10.1016/j.clgc.2024.102099. Epub 2024 Apr 24.

2024
AOU Novara

Gambale E; Maruzzo M; Messina C; De Gennaro Aquino I; Vascotto IA; Rossi V; Bimbatti D; Cavasin N; Messina M; Mennitto A; Rebuzzi SE; Nasso C; Mercinelli C; Maiorano BA; Fanelli M; Sorarù M; Scolari F; Mela MM; Galli L; Salfi A; Rizzo M; Puglisi S; Orlando V; Fornarini G; Rametta A; Giannatempo P; Cerbone L; Doni L; Roviello G; et alii...

Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study. in Cancer immunology, immunotherapy : CII / Cancer Immunol Immunother. 2024 Apr 18;73(6):106. doi: 10.1007/s00262-024-03682-w.

2024
ASL Cuneo 2
AOU Novara

Mosca A; Morelli F; Bisonni R; Bamias A; Santini D; Herchhorn D; Kanesvaran R; Inman E; Caitano M; Messina C; Martignetti A; Kopecky J; Milella M; Procopio G; Abahssain H; Roviello G; Kopp RM; Bassanelli M; Fernandez M; Cutuli HJ; Grillone F; Aceituno LG; Seront E; de Carvalho Fernandes R; Nogueira L; Mennitto A; Dauster B; Monteiro FSM; Barillas A; et alii...

Clinico-Pathological Features Influencing the Prognostic Role of Body Mass Index in Patients With Advanced Renal Cell Carcinoma Treated by Immuno-Oncology Combinations (ARON-1). in Clinical genitourinary cancer / Clin Genitourin Cancer. 2023 Oct;21(5):e309-e319.e1. doi: 10.1016/j.clgc.2023.03.006. Epub 2023 Mar

2023
AOU Novara

Santoni M; Massari F; Myint ZW; Iacovelli R; Pichler M; Basso U; Kopecky J; Kucharz J; Buti S; Salfi A; Büttner T; De Giorgi U; Kanesvaran R; Fiala O; Grande E; Zucali PA; Fornarini G; Bourlon MT; Scagliarini S; Molina-Cerrillo J; Aurilio G; Matrana MR; Pichler R; Cattrini C; Büchler T; Seront E; Calabrò F; Pinto A; Berardi R; et alii...

Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study. in Cancer immunology, immunotherapy : CII / Cancer Immunol Immunother. 2023 Nov;72(11):3665-3682. doi: 10.1007/s00262-023-03518-z. Epub 2023 Sep

2023
AOU Novara

Fiala O; Buti S; Takeshita H; Okada Y; Massari F; Palacios GA; Dionese M; Scagliarini S; Büttner T; Fornarini G; Myint ZW; Galli L; Souza VC; Pichler R; De Giorgi U; Quiroga MNG; Gilbert D; Popovic L; Grande E; Mammone G; Berardi R; Crabb SJ; Molina-Cerrillo J; Freitas M; Luz M; Iacovelli R; Calabrò F; Tural D; Atzori F; et alii...

Global Real-World Outcomes of Patients Receiving Immuno-Oncology Combinations for Advanced Renal Cell Carcinoma: The ARON-1 Study. in Targeted oncology / Target Oncol. 2023 Jul;18(4):559-570. doi: 10.1007/s11523-023-00978-2. Epub 2023 Jun 27.

2023
AOU Novara

Santoni M; Massari F; Myint ZW; Iacovelli R; Pichler M; Basso U; Kopecky J; Kucharz J; Buti S; Rizzo M; Galli L; Büttner T; De Giorgi U; Kanesvaran R; Fiala O; Grande E; Zucali PA; Fornarini G; Bourlon MT; Scagliarini S; Molina-Cerrillo J; Aurilio G; Matrana MR; Pichler R; Cattrini C; Büchler T; Seront E; Calabrò F; Pinto A; et alii...

In-Hospital Predictors of Need for Ventilatory Support and Mortality in Chest Trauma: A Multicenter Retrospective Study. in Journal of clinical medicine / J Clin Med. 2023 Jan 16;12(2):714. doi: 10.3390/jcm12020714.

2023
AOU Alessandria
AOU Novara

Vaschetto R; Della Corte F; Castello LM; Altomare M; Ragozzino R; Maestrone M; Spota A; Motta A; Marcomini N; Rizzo M; Virdis F; Ingala S; Cioffi SPB; Matranga S; Airoldi C; Fattori S; Iannantuoni G; Gavelli F; Reitano E; Avanzi GC; Chiara O; Cimbanassi S;

Geographical differences in the management of metastatic de novo renal cell carcinoma in the era of immune-combinations. in Minerva urology and nephrology / Minerva Urol Nephrol. 2023 Aug;75(4):460-470. doi: 10.23736/S2724-6051.23.05369-7.

2023
AOU Novara

Porta C; Bamias A; Zakopoulou R; Myint ZW; Cavasin N; Iacovelli R; Pichler M; Kopecky J; Kucharz J; Rizzo M; Galli L; Büttner T; DE Giorgi U; Kanesvaran R; Fiala O; Grande E; Zucali PA; Kopp RM; Fornarini G; Bourlon MT; Scagliarini S; Molina-Cerrillo J; Aurilio G; Matrana MR; Pichler R; Cattrini C; Büchler T; Massari F; Mollica V; et alii...

Oncological outcomes of active surveillance and percutaneous cryoablation of small renal masses are similar at intermediate term follow-up. in Minerva urology and nephrology / Minerva Urol Nephrol. 2022 Jun;74(3):321-328. doi: 10.23736/S2724-6051.21.04217-X. Epub 2021 Mar 29.

2022
AOU Novara

Umari P; Rizzo M; Billia M; Stacul F; Bertolotto M; Cova MA; Bondonno G; Perri D; Liguori G; Volpe A; Trombetta C;

Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study. in Journal of personalized medicine / J Pers Med. 2022 Apr 30;12(5):727. doi: 10.3390/jpm12050727.

2022
ASL Asti
AOU Novara

Fassan M; Sbaraglia M; Galuppini F; Aberasturi Plata Y; Zito-Marino F; Franco R; Rizzo M; Massari F; Cossarizza A; Bollito E; Salvioni R; Conti G; Lapini A; Colombo P; Patriarca C; Pierconti F; Basso U; Maruzzo M; Munari E; Atzori F; Montagnani I; Gobbo S; Umari P; Mosca A; Iacovelli R; Pappagallo G; Alongi F; Eccher A; Ortega C; et alii...

GU-CA-COVID: a clinical audit among Italian genitourinary oncologists during the first COVID-19 outbreak. in Therapeutic advances in urology / Ther Adv Urol. 2021 Oct 22;13:17562872211054302. doi: 10.1177/17562872211054302. eCollection 2021 Ja

2021
AOU Novara

Bersanelli M; Buti S; Rizzo M; Cortellini A; Cattrini C; Massari F; Masini C; Vitale MG; Fornarini G; Caffo O; Atzori F; Gatti A; Macrini S; Mucciarini C; Galli L; Morelli F; Stellato M; Fanelli M; Corti F; Zucali PA; Toscani I; Dalla Volta A; Gernone A; Baldessari C; La Torre L; Zara D; Gennari A; Bracarda S; Procopio G; et alii...

An Observational Cohort Study Investigating the Incidence Rate of Infectious Complications After Routine Office Nephrostomy Tube Replacement Without Using Antimicrobial Prophylaxis. in Urology / Urology. 2021 Jan;147:27-32. doi: 10.1016/j.urology.2020.10.020. Epub 2020 Oct 24.

2021
AOU Novara

Trombetta C; Bucci S; Umari P; Cai T; Claps F; Ongaro L; Rizzo M; Liguori G;

Re: "Immediate Shockwave Lithotripsy vs Delayed Shockwave Lithotripsy After Urgent Ureteral Stenting in Patients with Ureteral or Pyeloureteral Urolithiasis: A Matched-Pair Analysis" by Cornelius et al. in Journal of endourology / J Endourol. 2021 Aug;35(8):1275. doi: 10.1089/end.2021.0116.

2021
AOU Novara

Rizzo M; Umari P; Bucci S; Trombetta C;

Perioperative Antimicrobial Prophylaxis for Preventing Infectious Complications After Transurethral Resection of the Bladder: To Use or Not to Use? in Journal of endourology / J Endourol. 2020 Feb;34(2):198-202. doi: 10.1089/end.2019.0523.

2020
AOU Novara

Rizzo M; Verzotti E; Di Cosmo G; Cai T; Pavan N; Bonkat G; Umari P; Cocci A; Trombetta C; Liguori G;

Needle tract seeding after percutaneous cryoablation of small renal masses; a case series and literature review. in Scandinavian journal of urology / Scand J Urol. 2020 Apr;54(2):122-127. doi: 10.1080/21681805.2020.1736149. Epub 2020 Mar 10.

2020
AOU Novara

Rizzo M; Cabas P; Pavan N; Umari P; Verzotti E; Boltri M; Stacul F; Bertolotto M; Liguori G; Trombetta C;

Targeting angiogenesis in metastatic renal cell carcinoma. in Expert review of anticancer therapy / Expert Rev Anticancer Ther. 2019 Mar;19(3):245-257. doi: 10.1080/14737140.2019.1574574. Epub 2019 Fe

2019
AOU Novara

Canino C; Perrone L; Bosco E; Saltalamacchia G; Mosca A; Rizzo M; Porta C;

Sunitinib, pazopanib or sorafenib for the treatment of patients with late relapsing metastatic renal cell carcinoma. in The Journal of urology / J Urol. 2015 Jan;193(1):41-7. doi: 10.1016/j.juro.2014.07.011. Epub 2014 Jul 18.

2015
AOU Novara

Santoni M; Conti A; Porta C; Procopio G; Sternberg CN; Basso U; De Giorgi U; Bracarda S; Rizzo M; Ortega C; Massari F; Iacovelli R; Derosa L; Masini C; Milella M; Di Lorenzo G; Atzori F; Pagano M; Buti S; De Vivo R; Mosca A; Rossi M; Paglino C; Verzoni E; Cerbone L; Muzzonigro G; Falconi M; Montironi R; Burattini L; et alii...